Whitehawk Therapeutics (WHWK) Current Assets (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Current Assets of $125.5 million for Q1 2026, down 46.03% year-over-year from $232.6 million in Q1 2025, and down 15.75% quarter-over-quarter from $149.0 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Current Assets (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Current Assets for 15 consecutive years, with $125.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 46.03% year-over-year to $125.5 million; the TTM figure through Mar 2026 stood at $125.5 million (down 46.03% YoY), while the FY2025 annual figure was $149.0 million, up 143.14% from the prior year.
- Current Assets declined to $125.5 million in Q1 2026 per WHWK's latest filing, from $149.0 million in the prior quarter.
- Across five years, Current Assets topped out at $232.6 million in Q1 2025 and bottomed at $61.3 million in Q4 2024.
- Historically, Current Assets has averaged $140.1 million across 5 years, with a median of $135.6 million in 2022.
- Annual changes were most pronounced in 2022 — Current Assets soared 232.49% — and 2024, when it sank 50.81%.
- Whitehawk Therapeutics' Current Assets stood at $180.0 million in 2022, then sank by 30.8% to $124.6 million in 2023, then sank by 50.81% to $61.3 million in 2024, then jumped by 143.14% to $149.0 million in 2025, then decreased by 15.75% to $125.5 million in 2026.
- Business Quant data shows WHWK's Current Assets at $125.5 million in Q1 2026, $149.0 million in Q4 2025, and $165.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | 192.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 192.41 Mn |
| Mar 31, 2026 | 125.55 Mn |
| Dec 31, 2025 | 149.01 Mn |
| Sep 30, 2025 | 165.04 Mn |
| Jun 30, 2025 | 178.67 Mn |
| Mar 31, 2025 | 232.61 Mn |
| Dec 31, 2024 | 61.29 Mn |
| Sep 30, 2024 | 77.32 Mn |
| Jun 30, 2024 | 93.01 Mn |
| Mar 31, 2024 | 102.57 Mn |
| Dec 31, 2023 | 124.59 Mn |
| Sep 30, 2023 | 132.88 Mn |
| Jun 30, 2023 | 144.92 Mn |
| Mar 31, 2023 | 164.93 Mn |
| Dec 31, 2022 | 180.03 Mn |
| Sep 30, 2022 | 189.86 Mn |
| Jun 30, 2022 | 124.34 Mn |
| Mar 31, 2022 | 135.62 Mn |
| Dec 31, 2021 | 151.27 Mn |
| Sep 30, 2021 | 162.02 Mn |